Upgrade to SI Premium - Free Trial

NSRX (NSRX)

2.91 -0.12 (3.96%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/2/26)

Latest Headlines

Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - Globe NewsWire Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum June 22, 2026 8:00 AM - Globe NewsWire Form 4 Nasus Pharma Ltd For: Jun 17 Filed by: Teleman Dan Benjamin June 22, 2026 7:13 AM - SEC Filing Nasus Pharma (NSRX) Reiterated at Market Outperform by Citizens June 11, 2026 5:15 AM - StreetInsider Form 6-K Nasus Pharma Ltd For: Jun 09 June 9, 2026 4:07 PM - SEC Filing Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron June 9, 2026 8:01 AM - StreetInsider Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)  June 9, 2026 8:00 AM - Globe NewsWire Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis June 1, 2026 8:00 AM - Globe NewsWire Form S-8 Nasus Pharma Ltd May 26, 2026 5:20 PM - SEC Filing Form SCHEDULE 13G Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P. May 15, 2026 6:36 AM - SEC Filing Nasus Pharma to Participate in Upcoming Investor Conferences May 1, 2026 9:14 AM - StreetInsider Nasus Pharma to Participate in Upcoming Investor Conferences May 1, 2026 9:14 AM - Globe NewsWire Full Article List